Suppr超能文献

用格里菲斯菌素封闭1型人类免疫缺陷病毒糖蛋白120上的甘露糖部分,可增强小鼠对这两种蛋白的抗体反应。

Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.

作者信息

Banerjee Kaustuv, Michael Elizabeth, Eggink Dirk, van Montfort Thijs, Lasnik Amanda B, Palmer Kenneth E, Sanders Rogier W, Moore John P, Klasse Per Johan

机构信息

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10021, USA.

出版信息

AIDS Res Hum Retroviruses. 2012 Feb;28(2):206-14. doi: 10.1089/aid.2011.0101. Epub 2011 Jul 27.

Abstract

To assess the influence of mannosylated glycans on the immunogenicity of human immunodeficiency virus type 1 (HIV-1) Env proteins, we immunized mice with monomeric gp120 in the presence and absence of the mannose-binding protein, griffithsin (GRFT). For comparison, other groups of mice received the nonglycosylated HIV-1 Gag protein, with and without GRFT. Coimmunization with GRFT increased the anti-gp120 IgG reactivity significantly, but had no effect on the anti-Gag response. We also investigated the IgG response to GRFT and found that gp120, but not Gag, enhanced its immunogenicity. For both proteins, IgG1 antibodies dominated the IgG response, with IgG2b as the next most prevalent subclass. We conclude that gp120-GRFT complexes are more immunogenic than the free proteins, for both components, and that occluding the mannose moieties on monomeric gp120 can improve the humoral immune response to this protein.

摘要

为了评估甘露糖基化聚糖对1型人类免疫缺陷病毒(HIV-1)Env蛋白免疫原性的影响,我们在有和没有甘露糖结合蛋白——格里菲斯菌素(GRFT)存在的情况下,用单体gp120免疫小鼠。为作比较,其他几组小鼠分别接受了无糖基化的HIV-1 Gag蛋白,同样分为有和没有GRFT的情况。与GRFT共同免疫显著增加了抗gp120 IgG反应性,但对抗Gag反应没有影响。我们还研究了对GRFT的IgG反应,发现gp120而非Gag增强了其免疫原性。对于这两种蛋白,IgG1抗体在IgG反应中占主导,IgG2b是其次最普遍的亚类。我们得出结论,对于两种成分而言,gp120-GRFT复合物比游离蛋白更具免疫原性,并且封闭单体gp120上的甘露糖部分可以改善对该蛋白的体液免疫反应。

相似文献

引用本文的文献

1
The Antiviral Potential of Algal Lectins.藻类凝集素的抗病毒潜力。
Mar Drugs. 2023 Sep 28;21(10):515. doi: 10.3390/md21100515.

本文引用的文献

2
Is developing an HIV-1 vaccine possible?开发 HIV-1 疫苗是否可行?
Curr Opin HIV AIDS. 2010 Sep;5(5):362-7. doi: 10.1097/COH.0b013e32833d2e90.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验